Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Stage Estrogen Receptor (ER) Positive Breast Cancer”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Large-scale testing (Phase 3)Study completedNCT00553358
What this trial is testing

Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 455
Not applicableStudy completedNCT03719495
What this trial is testing

Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer

Who this might be right for
Breast CancerEstrogen Receptor-positive Breast CancerHealthy
Duke University 68
Not applicableLooking for participantsNCT07262138
What this trial is testing

Active Surveillance in Older Women With ER+ Breast Cancer

Who this might be right for
Early Stage Estrogen Receptor (ER) Positive Breast Cancer
University of Pittsburgh 50
Not applicableStudy completedNCT01928186
What this trial is testing

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+7 more
University of Washington 28
Testing effectiveness (Phase 2)Looking for participantsNCT06452394
What this trial is testing

NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline

Who this might be right for
Breast Cancer
Swiss Cancer Institute 50
Early research (Phase 1)Looking for participantsNCT05870579
What this trial is testing

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 48
Not applicableStudy completedNCT01535066
What this trial is testing

S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer

Who this might be right for
Breast CancerPain
SWOG Cancer Research Network 226
Not applicableTemporarily pausedNCT07136493
What this trial is testing

Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+4 more
City of Hope Medical Center 350
Testing effectiveness (Phase 2)Active Not RecruitingNCT03573648
What this trial is testing

Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33
Testing effectiveness (Phase 2)Study completedNCT05549505
What this trial is testing

A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery

Who this might be right for
Breast Cancer
Arvinas Inc. 152
Testing effectiveness (Phase 2)Study completedNCT02526498
What this trial is testing

Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery

Who this might be right for
Ductal Breast Carcinoma In SituEstrogen Receptor PositiveInvasive Breast Carcinoma+4 more
Rutgers, The State University of New Jersey 200
Testing effectiveness (Phase 2)Study completedNCT01439282
What this trial is testing

Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast Cancer

Who this might be right for
Estrogen Receptor Positive TumorBreast Cancer
Eisai Inc. 77
Not applicableStudy completedNCT00755313
What this trial is testing

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityCognitive/Functional Effects+4 more
University of California, San Francisco 81
Testing effectiveness (Phase 2)Ended earlyNCT01430585
What this trial is testing

Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast Cancer

Who this might be right for
Early Breast Cancer (Phase 2)Advanced Breast Cancer (Phase 1b)
Pfizer 14
Large-scale testing (Phase 3)Not Yet RecruitingNCT07541079
What this trial is testing

A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)

Who this might be right for
Early Breast Cancer
Genentech, Inc. 300
Testing effectiveness (Phase 2)Ended earlyNCT01754519
What this trial is testing

Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery

Who this might be right for
Ductal Breast Carcinoma In SituEstrogen Receptor NegativeEstrogen Receptor Positive+12 more
Roswell Park Cancer Institute 1
Large-scale testing (Phase 3)Active Not RecruitingNCT04961996
What this trial is testing

A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)

Who this might be right for
Early Breast Cancer
Hoffmann-La Roche 4,170
Not applicableWithdrawnNCT00899639
What this trial is testing

Studying Tumor Tissue Samples From Patients With Early-Stage Breast Cancer

Who this might be right for
Breast Cancer
Rutgers, The State University of New Jersey
Large-scale testing (Phase 3)Looking for participantsNCT06492616
What this trial is testing

Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Who this might be right for
Breast Cancer
Stemline Therapeutics, Inc. 4,220
Not applicableStudy completedNCT02347449
What this trial is testing

The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population

Who this might be right for
Hormone Receptor Positive Malignant Neoplasm of Breast
Sunnybrook Health Sciences Centre 100
Load More Results